Ignite Creation Date:
2024-05-05 @ 11:48 AM
Last Modification Date:
2024-10-26 @ 9:13 AM
Study NCT ID:
NCT00137462
Status:
COMPLETED
Last Update Posted:
2007-11-16
First Post:
2005-08-26
Brief Title:
Lipitor Trial To Study The Effect Of TorcetrpibAtorvastatin To Atorvastatin Alone
Sponsor:
Pfizer
Organization:
Pfizer
Study Overview
Official Title:
A Phase 3 Double-Blind Randomized Multisite Trial Of The Efficacy Safety And Tolerability Of The Fixed Combination TorcetrapibAtorvastatin Administered Orally Once Daily For 12 Months Compared To Atorvastatin Alone Titrated Based On NCEP ATP-III LDL-C Goals In Subjects With Fredrickson Types IIa And IIb Dyslipidemias
Status:
COMPLETED
Status Verified Date:
2006-12
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The Torcetrapib project was terminated on December 2 2006 due to safety findings
To look at various lipids in the blood of people with Fredrickson Type IIa and Type IIb mixed dyslipidemias
To look at various lipids in the blood of people with Fredrickson Type IIa and Type IIb mixed dyslipidemias
Detailed Description:
For additional information please call 1-800-718-1021
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None